drugset / Trial / NCT01497483
Drug-Drug Interaction Study With Pravastatin and Cyclosporine
Phase 1
Completed
21 enrolled
University of California, San Francisco
National Institute of General Medical Sciences (NIGMS) · collab
RandomizedCrossoverSingle-blindBasic science
Summary
This study will address the following question: Does cyclosporine affect the pharmacokinetics of pravastatin in healthy volunteers? Studies have shown that cyclosporine inhibits the organic anion transporter required for pravastatin transport into the liver, thus increasing pravastatin levels in the blood. The investigators hypothesize that this inhibition will vary among people based on genetic differences. This knowledge is important to help develop safer and more effective drug therapy with reduced side effects.
Timeline
- Start
- 2011-12
- Primary completion
- 2013-05
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclosporine | Peptide | 100 mg | — |
| Comparator | Pravastatin | Small molecule | 40 mg | — |
Indications
No indication recorded.